{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,18]],"date-time":"2026-09-18T08:37:54Z","timestamp":1789720674022,"version":"4.0.1"},"reference-count":33,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2017,10,1]],"date-time":"2017-10-01T00:00:00Z","timestamp":1506816000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"name":"\u201cDepression -mechanisms-therapy\u201d","award":["POIG.01.01.02-12-004\/09"],"award-info":[{"award-number":["POIG.01.01.02-12-004\/09"]}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Pharmacological Reports"],"published-print":{"date-parts":[[2017,10]]},"DOI":"10.1016\/j.pharep.2017.05.016","type":"journal-article","created":{"date-parts":[[2017,6,4]],"date-time":"2017-06-04T00:45:25Z","timestamp":1496537125000},"page":"985-994","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":54,"title":["Depressive-like neurochemical and behavioral markers of Parkinson\u2019s disease after 6-OHDA administered unilaterally to the rat medial forebrain bundle"],"prefix":"10.1007","volume":"69","author":[{"given":"Kinga","family":"Kami\u0144ska","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tomasz","family":"Lenda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jolanta","family":"Konieczny","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anna","family":"Czarnecka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"El\u017cbieta","family":"Lorenc-Koci","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","reference":[{"issue":"4","key":"10.1016\/j.pharep.2017.05.016_bib0005","doi-asserted-by":"crossref","first-page":"368","DOI":"10.1136\/jnnp.2007.131045","article-title":"Parkinson's disease: clinical features and diagnosis","volume":"79","author":"Jankovic","year":"2008","journal-title":"J Neurol Neurosurg Psychiatry"},{"issue":"5","key":"10.1016\/j.pharep.2017.05.016_bib0010","doi-asserted-by":"crossref","first-page":"464","DOI":"10.1016\/S1474-4422(09)70068-7","article-title":"Non-motor symptoms of Parkinson\u2019s disease: dopaminergic pathophysiology and treatment","volume":"8","author":"Chaudhuri","year":"2009","journal-title":"Lancet Neurol"},{"issue":"Suppl 2","key":"10.1016\/j.pharep.2017.05.016_bib0015","first-page":"S65","article-title":"Nonmotor manifestations of Parkinson\u2019s disease","volume":"64","author":"Simuni","year":"2008","journal-title":"Ann Neurol"},{"issue":"3","key":"10.1016\/j.pharep.2017.05.016_bib0020","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1016\/S0006-3223(03)00530-4","article-title":"Prevalence, etiology, and treatment of depression in Parkinson\u2019s disease","volume":"54","author":"McDonald","year":"2003","journal-title":"Biol Psychiatry"},{"issue":"3","key":"10.1016\/j.pharep.2017.05.016_bib0025","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1002\/cne.902870308","article-title":"Alterations in catecholamine neurons of the locus coeruleus in senile dementia of the Alzheimer type and in Parkinson\u2019s disease with and without dementia and depression","volume":"287","author":"Chan-Palay","year":"1989","journal-title":"J Comp Neurol"},{"issue":"1","key":"10.1016\/j.pharep.2017.05.016_bib0030","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1016\/0006-8993(90)90733-R","article-title":"Loss of brainstem serotonin- and substance P-containing neurons in Parkinson\u2019s disease","volume":"510","author":"Halliday","year":"1990","journal-title":"Brain Res"},{"issue":"6","key":"10.1016\/j.pharep.2017.05.016_bib0035","doi-asserted-by":"crossref","first-page":"743","DOI":"10.1097\/00005072-199111000-00006","article-title":"The neuropathologic basis of different clinical subgroups of Parkinson's disease","volume":"50","author":"Paulus","year":"1991","journal-title":"J Neuropathol Exp Neurol"},{"issue":"1","key":"10.1016\/j.pharep.2017.05.016_bib0040","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1007\/s00441-004-0956-9","article-title":"Stages in the development of Parkinson\u2019s disease-related pathology","volume":"318","author":"Braak","year":"2004","journal-title":"Cell Tissue Res"},{"issue":"Suppl. 1","key":"10.1016\/j.pharep.2017.05.016_bib0045","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1055\/s-2007-1014317","article-title":"Anhedonia in schizophrenic, depressed, or alcohol-dependent patients\u2013neurobiological correlates","volume":"27","author":"Heinz","year":"1994","journal-title":"Pharmacopsychiatry"},{"key":"10.1016\/j.pharep.2017.05.016_bib0050","doi-asserted-by":"crossref","first-page":"1314","DOI":"10.1093\/brain\/awh445","article-title":"Depression in Parkinson\u2019s disease: loss of dopamine and noradrenaline innervation in the limbic system","volume":"128","author":"Remy","year":"2005","journal-title":"Brain"},{"issue":"Pt 1","key":"10.1016\/j.pharep.2017.05.016_bib0055","first-page":"120","article-title":"Preferential loss of serotonin markers in caudate versus putamen in Parkinson's disease","volume":"131","author":"Kish","year":"2008","journal-title":"Brain"},{"issue":"1","key":"10.1016\/j.pharep.2017.05.016_bib0060","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/0006-8993(94)91761-2","article-title":"Noradrenaline, dopamine and serotonin levels and metabolism in the human hypothalamus: observations in Parkinson\u2019s disease and normal subjects","volume":"639","author":"Shannak","year":"1994","journal-title":"Brain Res"},{"issue":"2","key":"10.1016\/j.pharep.2017.05.016_bib0065","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1002\/ana.410220207","article-title":"Aminergic systems in Alzheimer's disease and Parkinson\u2019s disease","volume":"22","author":"D'Amato","year":"1987","journal-title":"Ann Neurol"},{"issue":"2","key":"10.1016\/j.pharep.2017.05.016_bib0070","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1016\/0006-8993(83)90993-9","article-title":"Reduction of cortical dopamine, noradrenaline, serotonin and their metabolites in Parkinson's disease","volume":"275","author":"Scatton","year":"1983","journal-title":"Brain Res"},{"issue":"2","key":"10.1016\/j.pharep.2017.05.016_bib0075","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1016\/j.bbr.2007.07.002","article-title":"Lesions of dopaminergic neurons in the substantia nigra pars compacta and in the ventral tegmental area enhance depressive-like behavior in rats","volume":"184","author":"Winter","year":"2007","journal-title":"Behav Brain Res"},{"issue":"9","key":"10.1016\/j.pharep.2017.05.016_bib0080","doi-asserted-by":"crossref","first-page":"2050","DOI":"10.1002\/jnr.21642","article-title":"Nonmotor symptoms in Parkinson's disease: investigating early-phase onset of behavioral dysfunction in the 6-hydroxydopamine-lesioned rat model","volume":"86","author":"Branchi","year":"2008","journal-title":"J Neurosci Res"},{"issue":"4","key":"10.1016\/j.pharep.2017.05.016_bib0085","doi-asserted-by":"crossref","first-page":"830","DOI":"10.1016\/j.neuroscience.2008.08.035","article-title":"Emotional, cognitive and neurochemical alterations in a premotor stage model of Parkinson's disease","volume":"156","author":"Tadaiesky","year":"2008","journal-title":"Neuroscience"},{"issue":"6","key":"10.1016\/j.pharep.2017.05.016_bib0090","doi-asserted-by":"crossref","first-page":"1545","DOI":"10.1016\/S1734-1140(13)71516-0","article-title":"Depression in Parkinson\u2019s disease","volume":"65","author":"Ossowska","year":"2013","journal-title":"Pharmacol Rep"},{"key":"10.1016\/j.pharep.2017.05.016_bib0095","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1016\/j.bbr.2013.10.035","article-title":"Induction of depressive-like behavior by intranigral 6-OHDA is directly correlated with deficits in striatal dopamine and hippocampal serotonin","volume":"259","author":"Santiago","year":"2014","journal-title":"Behav Brain Res"},{"issue":"2-3","key":"10.1016\/j.pharep.2017.05.016_bib0100","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1016\/S0301-0082(96)00040-8","article-title":"The unilateral 6-hydroxydopamine lesion model in behavioral brain research. Analysis of functional deficits, recovery and treatments","volume":"50","author":"Schwarting","year":"1996","journal-title":"Prog Neurobiol"},{"issue":"1","key":"10.1016\/j.pharep.2017.05.016_bib0105","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/0014-2999(76)90352-6","article-title":"Iversen SD: selective 6-OHDA-induced destruction of mesolimbic dopamine neurons: abolition of psychostimulant-induced locomotor activity in rats","volume":"40","author":"Kelly","year":"1976","journal-title":"Eur J Pharmacol"},{"issue":"8","key":"10.1016\/j.pharep.2017.05.016_bib0110","doi-asserted-by":"crossref","first-page":"790","DOI":"10.1016\/j.neuint.2013.09.021","article-title":"a nitric oxide donor, modulates rotational behavior and monoamine metabolism in 6-OHDA lesioned rats treated chronically with L-DOPA","volume":"63","author":"Lorenc-Koci","year":"2013","journal-title":"Neurochem Int"},{"key":"10.1016\/j.pharep.2017.05.016_bib0115","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1016\/j.brainres.2013.10.011","article-title":"\u015amia\u0142owska M, Lorenc-Koci E Alterations in the expression of nNOS in the substantia nigra and subthalamic nucleus of 6-OHDA-lesioned rats: the effects of chronic treatment with l-DOPA and the nitric oxide donor, molsidomine","volume":"1541","author":"Czarnecka","year":"2013","journal-title":"Brain Res"},{"issue":"2","key":"10.1016\/j.pharep.2017.05.016_bib0120","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1007\/BF02244188","article-title":"An animal model of anhedonia: attenuation of sucrose consumption and place preference conditioning by chronic unpredictable mild stress","volume":"104","author":"Papp","year":"1991","journal-title":"Psychopharmacology (Berl)"},{"issue":"4","key":"10.1016\/j.pharep.2017.05.016_bib0125","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1007\/s00213-006-0630-x","article-title":"Evaluation of reward processes in an animal model of depression","volume":"190","author":"Slattery","year":"2007","journal-title":"Psychopharmacology (Berl)"},{"key":"10.1016\/j.pharep.2017.05.016_bib0130","series-title":"The Rat Brain in Stereotaxic Coordinates","author":"Paxinos","year":"1986"},{"key":"10.1016\/j.pharep.2017.05.016_bib0135","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1016\/j.expneurol.2013.03.002","article-title":"Performance of movement in hemiparkinsonian rats influences the modifications induced by dopamine agonists in striatal efferent dynorphinergic neurons","volume":"247","author":"Frau","year":"2013","journal-title":"Exp Neurol"},{"issue":"2","key":"10.1016\/j.pharep.2017.05.016_bib0140","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1006\/exnr.2002.7891","article-title":"Modeling Parkinson\u2019s disease in rats: an evaluation of 6-OHDA lesions of the nigrostriatal pathway","volume":"175","author":"Deumens","year":"2002","journal-title":"Exp Neurol"},{"issue":"3","key":"10.1016\/j.pharep.2017.05.016_bib0145","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1002\/cne.902430307","article-title":"Steindler DA, Kitai ST: the organization of divergent axonal projections from the midbrain raphe nuclei in the rat","volume":"243","author":"Imai","year":"1986","journal-title":"J Comp Neurol."},{"issue":"Suppl. 2","key":"10.1016\/j.pharep.2017.05.016_bib0150","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1080\/13651500701388310","article-title":"El Mansari M: The importance of serotonin and noradrenaline in anxiety","volume":"11","author":"Blier","year":"2007","journal-title":"Int J Psychiatry Clin Pract"},{"issue":"1","key":"10.1016\/j.pharep.2017.05.016_bib0155","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1006\/exnr.1994.1039","article-title":"Unilateral destruction of dopamine pathways increases ipsilateral striatal serotonin turnover in rats","volume":"126","author":"Karstaedt","year":"1994","journal-title":"Exp Neurol"},{"issue":"Suppl 1","key":"10.1016\/j.pharep.2017.05.016_bib0160","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1097\/00004850-199403001-00004","article-title":"Pharmacological characterization of selective serotonin reuptake inhibitors (SSRIs)","volume":"9","author":"Hyttel","year":"1994","journal-title":"Int Clin Psychopharmacol"},{"issue":"1\u20132","key":"10.1016\/j.pharep.2017.05.016_bib0165","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1016\/j.neulet.2006.03.059","article-title":"Reuptake of L-DOPA-derived extracellular dopamine in the striatum with dopaminergic denervation via serotonin transporters","volume":"402","author":"Kannari","year":"2006","journal-title":"Neurosci Lett"}],"container-title":["Pharmacological Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1734114017302311?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1734114017302311?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,7,15]],"date-time":"2025-07-15T20:37:10Z","timestamp":1752611830000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1016\/j.pharep.2017.05.016"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,10]]},"references-count":33,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2017,10]]}},"alternative-id":["S1734114017302311"],"URL":"https:\/\/doi.org\/10.1016\/j.pharep.2017.05.016","relation":{},"ISSN":["1734-1140"],"issn-type":[{"value":"1734-1140","type":"print"}],"subject":[],"published":{"date-parts":[[2017,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Depressive-like neurochemical and behavioral markers of Parkinson\u2019s disease after 6-OHDA administered unilaterally to the rat medial forebrain bundle","name":"articletitle","label":"Article Title"},{"value":"Pharmacological Reports","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.pharep.2017.05.016","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 Institute of Pharmacology, Polish Academy of Sciences. Published by Elsevier Sp. z o.o. All rights reserved.","name":"copyright","label":"Copyright"}]}}